Evidence map›Paper›PMID 42842153›Full record

ArticleInternational journal of clinical pharmacy2026

Proportion of patients admitted to rural and remote hospitals that experience a 30-day medication-related readmission: a retrospective cohort study.

Kingston Yeung, Gi Kon Nam, Klaudia Englezos, Aagam Bordia, Stephen Carter, Rebekah Moles, Hana Amer, Manya Angley, Charley Budgeon, Brett Chambers and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Kingston YeungFaculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia. kingston.yeung@sydney.edu.au.ORCID https://orcid.org/0000-0002-1813-9620
Gi Kon NamFaculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0009-0001-5017-2869
Klaudia EnglezosFaculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
Aagam BordiaDepartment of Pharmacy, The Royal North Shore Hospital, St Leonards, NSW, Australia.ORCID http://orcid.org/0009-0009-9322-4102
Stephen CarterFaculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-4670-0884
Rebekah MolesFaculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-4043-6728
Hana AmerFaculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-0248-7241
Manya AngleySchool of Health and Clinical Sciences, University of Western Australia, Perth, WA, Australia.ORCID http://orcid.org/0000-0001-6735-9876
Charley BudgeonSchool of Population and Global Health, University of Western Australia, Perth, WA, Australia.ORCID http://orcid.org/0000-0002-1910-5561
Brett ChambersWestern NSW Local Health District, Dubbo, NSW, Australia.ORCID http://orcid.org/0000-0001-5717-6099
Jenny ChenFaculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0009-0007-5920-8702
Deirdre CriddleComplex Needs Coordination Team and Sir Charles Gairdner Hospital Pharmacy Department, Sir Charles Gairdner, Nedlands, WA, Australia.ORCID http://orcid.org/0000-0001-9455-1898
Rohan A ElliottDepartment of Pharmacy, Austin Health, Heidelberg, VIC, Australia.ORCID http://orcid.org/0000-0002-7750-9724
Tara EmadiFaculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-5053-4591
Cristen FlemingWestern NSW Local Health District, Dubbo, NSW, Australia.ORCID http://orcid.org/0000-0003-3870-0822
Deborah HawthorneDeborah Hawthorne Consultancy, Wangaratta, VIC, Australia.ORCID http://orcid.org/0009-0002-9301-0437
Linda KroghWestern NSW Local Health District, Dubbo, NSW, Australia.ORCID http://orcid.org/0009-0004-5831-7358
Anna PackerWestern NSW Local Health District, Dubbo, NSW, Australia.ORCID http://orcid.org/0000-0003-0372-4373
Simon PoonFaculty of Engineering, University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0003-2726-9109
Frank M SanfilippoSchool of Population and Global Health, University of Western Australia, Perth, WA, Australia.ORCID http://orcid.org/0000-0003-3639-0787
Paul YatesDepartment of Geriatric Medicine, Austin Health, Heidelberg, VIC, Australia.ORCID http://orcid.org/0000-0001-9317-0145
Jerry YikAdvanced Pharmacy Australia, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-1048-9116
Jonathan PenmFaculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-9606-7135

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMedication-related readmissions are a significant and preventable cause of patient harm. Patients living in rural and remote areas may face inequitable access to healthcare and fragmented continuity of care, increasing their vulnerability to medication-related harm. Despite this, the burden and drivers of medication-related readmissions in these settings remain poorly understood. Determining the current burden and identifying factors associated with medication-related readmissions is essential to inform targeted strategies to improve medication safety.

aimTo determine the proportion of adult patients with a medication-related readmission within 30 days of discharge from rural and remote hospitals, and to identify factors potentially associated with these readmissions.

methodA retrospective cohort study was conducted using medical records of adults admitted to rural and remote hospitals in New South Wales, Australia, between June 1, 2022 and August 31, 2023. Readmissions within 30 days were assessed for medication-related causes using the AT-HARM10, a validated 10-item tool based on admission notes, medication lists, inpatient pathology results, and discharge summaries. Patient demographics, comorbidities and admission details were extracted. Comorbidity burden was calculated using the Charlson Comorbidity Index (CCI). Medication lists were based on medications charted 12 h before discharge. Univariable logistic regression was performed to explore factors associated with 30-day medication-related readmissions, with results reported as unadjusted odds ratios (uOR).

resultsOf the 2220 patients admitted during the study period, 6% (n = 133) experienced a 30-day readmission, of which 22.5% (n = 30) were medication-related. Overall, 1.4% of all admitted patients experienced a 30-day medication-related readmission. Older age (uOR 1.04; 95% CI 1.01-1.07), higher CCI (uOR 1.22; 95% CI 1.04-1.44), a greater number of regular medications (uOR 1.07 per additional medication; 95% CI 1.01-1.14), and insulin use (uOR 2.80; 95% CI 1.06-7.42) were associated with medication-related readmission.

conclusionIn rural and remote hospitals, a small but clinically important proportion of patients experienced a medication-related readmission within 30 days of discharge. Unadjusted analysis identified that older age, multimorbidity, polypharmacy and insulin use were associated with increased risk. Larger studies are needed to validate these findings and evaluate strategies to reduce medication-related harm in rural and remote populations.

Indexed as

Drug-related problemsDrug-related readmissionsHospital readmissionMedication safetyRisk factors

Identifiers

PMID42842153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.